Cancer Medicine

Scientific research is performed in an environment that has a wealth of clinical expertise and research which ensures that basic scientific research is always performed with insights of relevance to patients provided by leading clinical teams and an awareness of detailed clinical issues.

Key Features

The research interests of the Cancer Medicine program offered by University of Liverpool include:

• Fundamental research into the mechanisms leading to cancer development and progression with the aim of understanding the processes that lead to cancer development and which constitute potential therapeutic targets

• Clinical studies conducted with the intent to advance therapies to the clinic or develop principles for application of therapeutics to human disease (part of the remit of the Cancer Research UK Experimental Cancer Medicine Centre)

• Investigations in humans and human materials which define the biology of disease and provide the scientific foundation for the development of new or improved therapies for human disease

• Translational research taking advantage of new and on-going clinical trials in cancer often of novel and modifications of existing therapies and also to develop novel predictive and prognostic biomarkers.

Facilities

• The Institute of Translational Medicine research infrastructure is designed to give researchers access to world class facilities in the best possible environment.
• The facilities give us the ability to drive biomedical research from patient samples to the laboratory bench and vice versa from newly generated drug compounds into clinical trials.

• Pancreatic cancer

• Haemato-Oncology

• Head and Neck cancer

• Liver Cancer

• Lung cancer

• Ocular cancers

• Colorectal cancer

• Gastro-oesophageal cancer

• Urological cancer (including Renal Cancer)

• Breast cancer